Monocyte Selectivity and Tissue Localization Suggests a Role for Breast and Kidney–Expressed Chemokine (Brak) in Macrophage Development
Open Access
- 17 September 2001
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 194 (6) , 855-862
- https://doi.org/10.1084/jem.194.6.855
Abstract
Although numerous chemokines act on monocytes, none of them is specific for these cells. Here, we show that breast and kidney–expressed chemokine (BRAK) is a highly selective monocyte chemoattractant. Migration efficacy and Bordetella pertussis toxin–sensitive Ca2+ mobilization responses to BRAK were strongly enhanced after treatment of monocytes with the cyclic AMP–elevating agents prostaglandin E2 and forskolin. BRAK is the first monocyte-selective chemokine, as other types of blood leukocytes or monocyte-derived dendritic cells and macrophages did not respond. Expression in normal skin keratinocytes and dermal fibroblasts as well as lamina propria cells in normal intestinal tissues suggests a homeostatic rather than an inflammatory function for this chemokine. In addition, macrophages were frequently found to colocalize with BRAK-producing fibroblasts. We propose that BRAK is involved in the generation of tissue macrophages by recruiting extravasated precursors to fibroblasts, which are known to secrete essential cytokines for macrophage development.Keywords
This publication has 27 references indexed in Scilit:
- Lymphocyte traffic control by chemokinesNature Immunology, 2001
- IL-6 switches the differentiation of monocytes from dendritic cells to macrophagesNature Immunology, 2000
- In Vivo Expression of the Novel CXC Chemokine BRAK in Normal and Cancerous Human TissueThe American Journal of Pathology, 2000
- B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR α-chemokineInternational Immunology, 2000
- Cloning of BRAK, a Novel Divergent CXC Chemokine Preferentially Expressed in Normal versus Malignant CellsBiochemical and Biophysical Research Communications, 1999
- Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin.The Journal of Experimental Medicine, 1996
- Enhanced expression of IL‐8 in normal human keratinocytes and human keratinocyte cell line HaCaT in vitro after stimulation with contact sensitizers., tolerogens and irritantsExperimental Dermatology, 1994
- Characterization of the inhibitory prostanoid receptors on human neutrophilsBritish Journal of Pharmacology, 1993
- Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide 2Biochemistry, 1991
- A novel neutrophil-activating factor produced by human mononuclear phagocytes.The Journal of Experimental Medicine, 1988